Dorota Borys

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Top Venues

Human vaccines & immunotherapeutics

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Byung-Wook Eun, Enas Bahar, Stebin Xavier, Hyungwoo Kim, Dorota Borys
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021). Human vaccines & immunotherapeutics 19 (1) (2023)
Byung-Wook Eun, Enas Bahar, Stebin Xavier, Hyungwoo Kim, Dorota Borys
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021). Human vaccines & immunotherapeutics 19 (1) (2023)
Byung-Wook Eun, Enas Bahar, Stebin Xavier, Hyungwoo Kim, Dorota Borys
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021). Human vaccines & immunotherapeutics (2023)
Byung-Wook Eun, Enas Bahar, Stebin Xavier, Hyungwoo Kim, Dorota Borys
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021). Human vaccines & immunotherapeutics 19 (1) (2023)
Byung-Wook Eun, Enas Bahar, Stebin Xavier, Hyungwoo Kim, Dorota Borys
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021). Human vaccines & immunotherapeutics 19 (1) (2023)
Sarah Welby, Dominique Rosillon, Yang Feng, Dorota Borys
Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016. Expert review of vaccines 21 (3) (2022)
Abiel Mascareñas de Los Santos, Miguel Angel Rodríguez-Weber, Pedro Sánchez-Márquez, Magali Traskine, Roberto Carreño-Manjarrez, María Yolanda Cervantes-Apolinar, Ana Strezova, Javier Ruiz-Guiñazú, Eduardo Ortega-Barria, Dorota Borys
Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine. Expert review of vaccines 19 (11) (2021)
Michael Horn, Ulrich Behre, Magali Traskine, Kurt Dobbelaere, Dorota Borys
Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial. Human vaccines & immunotherapeutics 17 (5) (2020)
Marta C Nunes, Marta Moreira, Anthonet Koen, Nadia van Niekerk, Lisa Jose, Clare L Cutland, Nancy François, Sonia Schoonbroodt, Javier Ruiz-Guiñazú, Juan Pablo Yarzabal, Dorota Borys, Lode Schuerman, Shabir Ahmed Madhi
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert review of vaccines 19 (12) (2020)
Javier Nieto Guevara, Dorota Borys, Rodrigo DeAntonio, Adriana Guzmán-Holst, Bernard Hoet
Interchangeability between pneumococcal conjugate vaccines for pediatric use: a systematic literature review. Expert review of vaccines 19 (11) (2019)